All figures shown in the chart above are for the trailing 12 month (TTM) period
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 6.0%.
Looking ahead, revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Switzerland.
It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Clariant, and understanding these should be part of your investment process.